Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 326
Filter
1.
Front Immunol ; 15: 1366125, 2024.
Article in English | MEDLINE | ID: mdl-38715615

ABSTRACT

Introduction: Patients with the multibacillary form of leprosy can develop reactional episodes of acute inflammation, known as erythema nodosum leprosum (ENL), which are characterized by the appearance of painful cutaneous nodules and systemic symptoms. Neutrophils have been recognized to play a role in the pathogenesis of ENL, and recent global transcriptomic analysis revealed neutrophil-related processes as a signature of ENL skin lesions. Methods: In this study, we expanded this analysis to the blood compartment, comparing whole blood transcriptomics of patients with non-reactional lepromatous leprosy at diagnosis (LL, n=7) and patients with ENL before administration of anti-reactional treatment (ENL, n=15). Furthermore, a follow-up study was performed with patients experiencing an ENL episode at the time of diagnosis and after 7 days of thalidomide treatment (THAL, n=10). Validation in an independent cohort (ENL=8; LL=7) was performed by RT-qPCR. Results: An enrichment of neutrophil activation and degranulation-related genes was observed in the ENL group, with the gene for the neutrophil activation marker CD177 being the most enriched gene of ENL episode when compared to its expression in the LL group. A more pro-inflammatory transcriptome was also observed, with increased expression of genes related to innate immunity. Validation in an independent cohort indicated that S100A8 expression could discriminate ENL from LL. Supernatants of blood cells stimulated in vitro with Mycobacterium leprae sonicate showed higher levels of CD177 compared to the level of untreated cells, indicating that the leprosy bacillus can activate neutrophils expressing CD177. Of note, suggestive higher CD177 protein levels were found in the sera of patients with severe/moderate ENL episodes when compared with patients with mild episodes and LL patients, highlighting CD177 as a potential systemic marker of ENL severity that deserves future confirmation. Furthermore, a follow-up study was performed with patients at the time of ENL diagnosis and after 7 days of thalidomide treatment (THAL, n=10). Enrichment of neutrophil pathways was sustained in the transcriptomic profile of patients undergoing treatment; however, important immune targets that might be relevant to the effect of thalidomide at a systemic level, particularly NLRP6 and IL5RA, were revealed. Discussion: In conclusion, our study reinforces the key role played by neutrophils in ENL pathogenesis and shed lights on potential diagnostic candidates and novel therapeutic targets that could benefit patients with leprosy.


Subject(s)
Erythema Nodosum , Gene Expression Profiling , Leprosy, Lepromatous , Neutrophil Activation , Neutrophils , Transcriptome , Humans , Erythema Nodosum/immunology , Erythema Nodosum/blood , Leprosy, Lepromatous/immunology , Leprosy, Lepromatous/diagnosis , Leprosy, Lepromatous/blood , Adult , Male , Neutrophils/immunology , Neutrophils/metabolism , Female , Middle Aged , GPI-Linked Proteins/genetics , Thalidomide , Receptors, Cell Surface/genetics , Leprostatic Agents/therapeutic use , Leprostatic Agents/pharmacology , Young Adult , Biomarkers , Isoantigens
2.
Am J Dermatopathol ; 43(12): e149-e157, 2021 Dec 01.
Article in English | MEDLINE | ID: mdl-34291740

ABSTRACT

ABSTRACT: Erythema nodosum leprosum (ENL) occurs as an immune-inflammatory complication of multibacillary leprosy (MBL), precipitated by an interaction between the host, bacilli, and the environment. This complication often causes significant morbidity due to systemic involvement and needs to be treated aggressively. T-regulatory cells (T-regs) are the immunomodulatory subset of T cells that are hypothesized to play a role in ENL. We have performed immunohistochemistry for FoxP3 (T-reg), CD3 (pan-T), CD4 (helper T), and CD8 (cytotoxic T) on 50 biopsy-proven cases of ENL along with 84 biopsy-proven cases of paucibacillary leprosy (PBL) (n = 49) and MBL (n = 35). Image morphometry was applied to objectively assess the relative preponderance of these subsets of T cells. The area fraction of T-regs showed a trend of reduction from PBL to MBL to ENL (P = 0.068), whereas the FoxP3:CD3 (T-reg: pan-T) ratio showed a significant reduction across these groups (P = 0.023). However, there was no significant difference of T-regs or FoxP3:CD3 ratio between MBL and ENL. The T-regs showed a significant positive correlation (P = 0.007) with the cytotoxic T cells in the skin biopsy. The presence of dermal eosinophils in ENL showed a trend association with the FoxP3:CD3 ratio (P = 0.05). Various histopathological parameters including epidermal spongiosis, dermal stromal edema, dermal ill-formed granuloma, and the presence of bacilli within the endothelium and vascular smooth muscle correlated with various T-cell subsets. Our study, one of the largest on this topic, objectively assessed the role of T-regs in the spectrum of leprosy. Nevertheless, the precipitation of ENL from MBL is probably not associated with the T-reg subset alone.


Subject(s)
Erythema Nodosum/immunology , Leprosy, Lepromatous/immunology , T-Lymphocytes, Regulatory/immunology , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Immunophenotyping , Infant , Male , Middle Aged , Young Adult
3.
Am J Clin Dermatol ; 22(3): 367-378, 2021 May.
Article in English | MEDLINE | ID: mdl-33683567

ABSTRACT

Erythema nodosum is the most common form of panniculitis and is characterized by tender erythematous nodules mainly in the lower limbs on the pretibial area. The exact cause of erythema nodosum is unknown, although it appears to be a hypersensitivity response to a variety of antigenic stimuli. Although the etiology is mostly idiopathic, ruling out an underlying disease is imperative before diagnosing primary erythema nodosum. Erythema nodosum can be the first sign of a systemic disease that is triggered by a large group of processes, such as infections, inflammatory diseases, neoplasia, and/or drugs. The most common identifiable causes are streptococcal infections, primary tuberculosis, sarcoidosis, Behçet disease, inflammatory bowel disease, drugs, and pregnancy. We propose a diagnostic algorithm to optimize the initial work-up, hence initiating prompt and accurate management of the underlying disease. The algorithm includes an initial assessment of core symptoms, diagnostic work-up, differential diagnosis, and recommended therapies. Several treatment options for the erythema nodosum lesions have been previously reported; nevertheless, these options treat the symptoms, but not the triggering cause. Making an accurate diagnosis will allow the physician to treat the underlying cause and determine an optimal therapeutic strategy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Erythema Nodosum/diagnosis , Skin/immunology , Diagnosis, Differential , Drug Therapy, Combination/methods , Erythema Nodosum/drug therapy , Erythema Nodosum/epidemiology , Erythema Nodosum/immunology , Humans , Incidence , Skin/pathology , Treatment Outcome
4.
Int J Infect Dis ; 103: 549-551, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33326870

ABSTRACT

Type 2 leprosy reaction (T2LR), or Erythema Nodosum Leprosum (ENL), often poses a therapeutic challenge to clinicians and commonly requires long courses of steroids for control. While immunosuppressants are known to achieve control and lower steroid dependence in T2LR, the prospect of managing a severe T2LR in conjunction with COVID-19, with the concern of worsening COVID-19 with long-term immunosuppression has not previously been encountered. We report a case of severe T2LR treated with oral steroids and methotrexate, with COVID-19 infection acquired during hospital stay, and a favourable outcome achieved despite the continued use of immunosuppressants. We discuss the possible reasons for this both in terms of the drug pharmacodynamics and the immunological profile of T2LR.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , COVID-19 Drug Treatment , Erythema Nodosum/drug therapy , Immunosuppressive Agents/therapeutic use , Leprosy, Lepromatous/drug therapy , Methotrexate/administration & dosage , SARS-CoV-2 , Adult , COVID-19/immunology , Erythema Nodosum/immunology , Humans , Leprosy, Lepromatous/immunology , Male
5.
Am J Dermatopathol ; 43(10): 700-706, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-33264135

ABSTRACT

ABSTRACT: Erythema nodosum leprosum (ENL) occurs as an immunological complication of multibacillary leprosy (MBL). The pathogenesis of ENL is long considered to be a T-cell-mediated process. The role of B cells and plasma cells in ENL is not well described in the literature. Therefore, we investigated the B-cell and plasma cell infiltrates in the skin biopsies of biopsy-proven cases of ENL by immunohistochemistry and image morphometry and compared the result with paucibacillary leprosy and MBL. Moreover, we sought a correlation of the B-cell and plasma cell infiltrates with different clinical, hematological, histopathological, and bacteriological parameters as well as the T-cell subsets in the skin biopsies. Our study highlighted a significant reduction in the number of B cells from paucibacillary leprosy to MBL to ENL, although there was no significant variation in the plasma cell infiltrate. The plasma cell infiltrate correlated with absolute neutrophilia in the blood and the presence of eosinophils in the ENL lesions. Both B cells and plasma cells positively correlated with CD4-positive T-helper cells and the CD8-positive cytotoxic T cells. Besides, the B cells also correlated positively with the CD3-positive pan T cells in the biopsy and negatively correlated with the T-regulatory:T-cell ratio. Our results suggested the role of B cells and plasma cells even at the tissue level in the pathobiogenesis of ENL.


Subject(s)
B-Lymphocytes/pathology , Erythema Nodosum/pathology , Leprosy, Lepromatous/pathology , Plasma Cells/pathology , Adolescent , Adult , Aged , Antigens, CD20/metabolism , B-Lymphocytes/metabolism , Blood Cell Count , Child , Child, Preschool , Eosinophils/pathology , Erythema Nodosum/blood , Erythema Nodosum/immunology , Female , Humans , Immunohistochemistry , Infant , Leprosy, Lepromatous/blood , Leprosy, Lepromatous/immunology , Leprosy, Paucibacillary/immunology , Leprosy, Paucibacillary/pathology , Male , Middle Aged , Neutrophils , Plasma Cells/metabolism , Syndecan-1/metabolism , T-Lymphocytes, Cytotoxic/pathology , T-Lymphocytes, Helper-Inducer/pathology , T-Lymphocytes, Regulatory/pathology , Young Adult
6.
United European Gastroenterol J ; 8(9): 1031-1044, 2020 11.
Article in English | MEDLINE | ID: mdl-32921269

ABSTRACT

Extra-intestinal manifestations (EIMs) of inflammatory bowel disease (IBD) occur frequently and contribute to morbidity and reduced quality of life. The musculoskeletal, ocular and cutaneous organ systems are frequently involved in IBD-related EIMs. By focusing on manifestations involving the joints, skin and eyes, this review will discuss the most common clinically relevant and burdensome EIMs that affect IBD patients, and strives for early recognition, adequate treatment and timely referral. For this purpose, we aimed to create a comprehensive overview on this topic, with the main focus on the treatment of reactive and associated EIMs, including spondyloarthropathies, pyoderma gangrenosum, erythema nodosum, psoriasis and anterior uveitis. The recently developed biologicals enable simultaneous treatment of inflammatory disorders. This review can be used as a helpful guide in daily clinical practice for physicians who are involved in the treatment of IBD patients.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Arthralgia/diagnosis , Colitis, Ulcerative/complications , Erythema Nodosum/diagnosis , Eye Diseases/diagnosis , Administration, Oral , Administration, Topical , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Arthralgia/drug therapy , Arthralgia/epidemiology , Arthralgia/immunology , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/immunology , Crohn Disease/complications , Crohn Disease/drug therapy , Crohn Disease/immunology , Diagnosis, Differential , Erythema Nodosum/drug therapy , Erythema Nodosum/epidemiology , Erythema Nodosum/immunology , Eye Diseases/drug therapy , Eye Diseases/epidemiology , Eye Diseases/immunology , Female , Humans , Mesalamine/administration & dosage , Mesalamine/adverse effects , Middle Aged , Prednisolone/therapeutic use , Prevalence , Treatment Outcome
7.
Inflamm Bowel Dis ; 26(7): e74-e75, 2020 06 18.
Article in English | MEDLINE | ID: mdl-32448913

ABSTRACT

In our case, we want to highlight the importance of screening for opportunistic infectious diseases in these immunosuppressed patients. We present the case of an erythema nodosum triggered by reactivation of Herpes Simplex Virus (HSV) in a patient with ulcerative colitis.


Subject(s)
Colitis, Ulcerative/immunology , Erythema Nodosum/immunology , Immunocompromised Host/drug effects , Stomatitis, Herpetic/immunology , Ankle/virology , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/virology , Erythema Nodosum/virology , Female , Humans , Medical Illustration , Palate, Soft/virology , Stomatitis, Herpetic/virology , Young Adult
8.
Immunohorizons ; 4(2): 47-56, 2020 02 07.
Article in English | MEDLINE | ID: mdl-32034084

ABSTRACT

Erythema nodosum leprosum (ENL) is an inflammatory complication in leprosy. Yet, the involvement of ENL neutrophils in the inflammatory response against Mycobacterium leprae remains poorly explored. Our primary aim was to investigate the utility of the surface expression of neutrophil IL-10R1 as an ENL biomarker and, secondarily, to evaluate whether leprosy or healthy M. leprae-stimulated neutrophils produce cytokines and are able to respond to IL-10. We, in this study, describe a subpopulation of circulating neutrophils of ENL patients that exclusively expressed IL-10R1, providing evidence that IL-10R1+ neutrophils are present in ENL lesions. It was also found that ENL neutrophils, but not those of nonreactional leprosy controls, were able to secret detectable levels of TNF ex vivo and the addition of IL-10 blocked TNF release. It was likewise observed that M. leprae-stimulated, healthy neutrophils expressed IL-10R1 in vitro, and ENL-linked cytokines were released by M. leprae-cultured neutrophils in vitro. Moreover, consistent with the presence of a fully functional IL-10R, the addition of IL-10 prevented the release of M. leprae-induced cytokines. Most importantly, dead M. leprae revealed its superior capacity to induce CCL4 and IL-8 in primary neutrophils over live Mycobacterium, suggesting that M. leprae may hamper the inflammatory machinery as an immune escape mechanism.


Subject(s)
Erythema Nodosum/immunology , Interleukin-10 Receptor alpha Subunit/metabolism , Interleukin-10/pharmacology , Leprosy, Lepromatous/immunology , Neutrophils/metabolism , Skin/immunology , Adult , Cells, Cultured , Cytokines/metabolism , Erythema Nodosum/drug therapy , Female , Humans , Inflammation Mediators/metabolism , Leprosy, Lepromatous/drug therapy , Male , Middle Aged , Mycobacterium leprae/immunology , Neutrophil Infiltration/drug effects , Neutrophils/drug effects , Neutrophils/microbiology , Thalidomide/therapeutic use , Young Adult
9.
Front Immunol ; 10: 495, 2019.
Article in English | MEDLINE | ID: mdl-30949168

ABSTRACT

Leprosy is an infectious disease caused by the intracellular bacillus Mycobacterium leprae that mainly affects the skin and peripheral nerves. One of the most intriguing aspects of leprosy is the diversity of its clinical forms. Paucibacillary patients are characterized as having less than five skin lesions and rare bacilli while the lesions in multibacillary patients are disseminated with voluminous bacilli. The chronic course of leprosy is often interrupted by acute episodes of an inflammatory immunological response classified as either reversal reaction or erythema nodosum leprosum (ENL). Although ENL is considered a neutrophilic immune-complex mediated condition, little is known about the direct role of neutrophils in ENL and leprosy disease overall. Recent studies have shown a renewed interest in neutrophilic biology. One of the most interesting recent discoveries was that the neutrophilic population is not homogeneous. Neutrophilic polarization leads to divergent phenotypes (e.g., a pro- and antitumor profile) that are dynamic subpopulations with distinct phenotypical and functional abilities. Moreover, there is emerging evidence indicating that neutrophils expressing CD64 favor systemic inflammation during ENL. In the present review, neutrophilic involvement in leprosy is discussed with a particular focus on ENL and the potential of neutrophils as clinical biomarkers and therapeutic targets.


Subject(s)
Leprosy/immunology , Neutrophils/immunology , Animals , Erythema Nodosum/immunology , Humans , Skin/immunology , Skin Diseases/immunology
10.
PLoS Negl Trop Dis ; 13(1): e0007089, 2019 01.
Article in English | MEDLINE | ID: mdl-30689631

ABSTRACT

BACKGROUND: Leprosy is a treatable infectious disease caused by Mycobacterium leprae. However, there is additional morbidity from leprosy-associated pathologic immune reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL), which occur in 1 in 3 people with leprosy, even with effective treatment of M. leprae. There is currently no predictive marker in use to indicate which people with leprosy will develop these debilitating immune reactions. Our peripheral blood mononuclear cell (PBMC) transcriptome analysis revealed that activation of the classical complement pathway is common to both RR and ENL. Additionally, differential expression of immunoglobulin receptors and B cell receptors during RR and ENL support a role for the antibody-mediated immune response during both RR and ENL. In this study, we investigated B-cell immunophenotypes, total and M. leprae-specific antibodies, and complement levels in leprosy patients with and without RR or ENL. The objective was to determine the role of these immune mediators in pathogenesis and assess their potential as biomarkers of risk for immune reactions in people with leprosy. METHODOLOGY/FINDINGS: We followed newly diagnosed leprosy cases (n = 96) for two years for development of RR or ENL. They were compared with active RR (n = 35), active ENL (n = 29), and healthy household contacts (n = 14). People with leprosy who subsequently developed ENL had increased IgM, IgG1, and C3d-associated immune complexes with decreased complement 4 (C4) at leprosy diagnosis. People who developed RR also had decreased C4 at leprosy diagnosis. Additionally, elevated anti-M. leprae antibody levels were associated with subsequent RR or ENL. CONCLUSIONS: Differential co-receptor expression and immunoglobulin levels before and during immune reactions intimate a central role for humoral immunity in RR and ENL. Decreased C4 and elevated anti-M. leprae antibodies in people with new diagnosis of leprosy may be risk factors for subsequent development of leprosy immune reactions.


Subject(s)
Antibodies, Bacterial/blood , Complement C3d/analysis , Complement C4/analysis , Erythema Nodosum/epidemiology , Immunoglobulin G/blood , Immunoglobulin M/blood , Leprosy, Lepromatous/epidemiology , Mycobacterium leprae/immunology , Adult , Aged , Antibodies, Bacterial/immunology , B-Lymphocytes/immunology , Complement C3d/immunology , Complement C4/immunology , Erythema Nodosum/blood , Erythema Nodosum/immunology , Female , Gene Expression Profiling , Humans , Immunity, Active/immunology , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Leprosy, Lepromatous/blood , Leprosy, Lepromatous/immunology , Male , Middle Aged , Risk Factors
11.
Am J Trop Med Hyg ; 100(2): 377-385, 2019 02.
Article in English | MEDLINE | ID: mdl-30652669

ABSTRACT

Type 2 reaction (T2R) or erythema nodosum leprosum (ENL), a sudden episode of acute inflammation predominantly affecting lepromatous leprosy patients (LL), characterized by a reduced cellular immune response. This possibly indicates a close relationship between the onset of T2R and the altered frequency, and functional activity of T lymphocytes, particularly of memory subsets. This study performed ex vivo and in vitro characterizations of T cell blood subpopulations from LL patients with or without T2R. In addition, the evaluation of activity of these subpopulations was performed by analyzing the frequency of these cells producing IFN-γ, TNF, and IL-10 by flow cytometry. Furthermore, the expression of transcription factors, for the differentiation of T cells, were analyzed by quantitative real-time polymerase chain reaction. Our results showed an increased frequency of CD8+/TNF+ effector memory T cells (TEM) among T2Rs. Moreover, there was evidence of a reduced frequency of CD4 and CD8+ IFN-γ-producing cells in T2R, and a reduced expression of STAT4 and TBX21. Finally, a significant and positive correlation between bacteriological index (BI) of T2R patients and CD4+/TNF+ and CD4+/IFN-γ+ T cells was observed. Thus, negative correlation between BI and the frequency of CD4+/IL-10+ T cells was noted. These results suggest that CD8+/TNF+ TEM are primarily responsible for the transient alteration in the immune response to Mycobacterium leprae in ENL patients. Thus, our study improves our understanding of pathogenic mechanisms and might suggest new therapeutic approaches for leprosy.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Erythema Nodosum/immunology , Leprosy, Lepromatous/immunology , Mycobacterium leprae/pathogenicity , Tumor Necrosis Factor-alpha/immunology , Adolescent , Adult , Aged , CD4-Positive T-Lymphocytes/microbiology , CD8-Positive T-Lymphocytes/microbiology , Case-Control Studies , Erythema Nodosum/genetics , Erythema Nodosum/pathology , Female , Gene Expression Regulation , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Humans , Immunologic Memory , Immunophenotyping , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-10/genetics , Interleukin-10/immunology , Leprosy, Lepromatous/genetics , Leprosy, Lepromatous/pathology , Male , Middle Aged , Mycobacterium leprae/growth & development , Mycobacterium leprae/immunology , Primary Cell Culture , STAT4 Transcription Factor/genetics , STAT4 Transcription Factor/immunology , Signal Transduction , T-Box Domain Proteins/genetics , T-Box Domain Proteins/immunology , Tumor Necrosis Factor-alpha/genetics
13.
PLoS Negl Trop Dis ; 12(12): e0007035, 2018 12.
Article in English | MEDLINE | ID: mdl-30592714

ABSTRACT

BACKGROUND: Erythema nodosum leprosum (ENL) is a systemic inflammatory complication occurring mainly in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL). Prednisolone is widely used for treatment of ENL reactions. However, it has been reported that prolonged treatment with prednisolone increases the risk for prednisolone-induced complications such as osteoporosis, diabetes, cataract and arteriosclerosis. It has been speculated that perhaps these complications result from lipid profile alterations by prednisolone. The effects of extended prednisolone treatment on lipid profiles in ENL patients have not been studied in leprosy patients with ENL reactions. Therefore, in this study we conducted a case-control study to investigate the changes in lipid profiles and serological responses in Ethiopian patients with ENL reaction after prednisolone treatment. METHODS: A prospective matched case-control study was employed to recruit 30 patients with ENL and 30 non-reactional LL patient controls at ALERT Hospital, Ethiopia. Blood samples were obtained from each patient with ENL reaction before and after prednisolone treatment as well as from LL controls. The serological host responses to PGL-1, LAM and Ag85 M. leprae antigens were measured by ELISA. Total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL) and low density lipoprotein (LDL) were measured by spectrophotometric method. RESULTS: The host antibody response to M. leprae PGL-1, LAM and Ag85 antigens were significantly reduced in patients with ENL reactions compared to LL controls after treatment. Comparison between patients with acute and chronic ENL showed that host-response to PGL-1 was significantly reduced in chronic ENL after prednisolone treatment. Untreated patients with ENL reactions had low lipid concentration compared to LL controls. However, after treatment, both groups had comparable lipid profiles except for LDL, which was significantly higher in patients with ENL reaction. Comparison within the ENL group before and after treatment showed that prednisolone significantly increased LDL and HDL levels in ENL patients and this was more prominent in chronic ENL than in acute patients with ENL. CONCLUSION: The significantly increased prednisolone-induced LDL and TG levels, particularly in patients with chronic ENL reactions, is a concern in the use of prednisolone for extended periods in ENL patients. The findings highlight the importance of monitoring lipid profiles during treatment of patients to minimize the long-term risk of prednisolone-induced complications.


Subject(s)
Erythema Nodosum/blood , Erythema Nodosum/drug therapy , Leprosy, Lepromatous/complications , Prednisolone/administration & dosage , Adolescent , Adult , Case-Control Studies , Cholesterol/blood , Erythema Nodosum/etiology , Erythema Nodosum/immunology , Female , Humans , Leprosy, Lepromatous/microbiology , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Male , Middle Aged , Mycobacterium leprae/physiology , Prednisolone/adverse effects , Prospective Studies , Triglycerides/blood , Young Adult
15.
Acta Trop ; 183: 134-141, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29474830

ABSTRACT

Erythema Nodosum Leprosum (ENL) occurs due to the immunological complication of multibacillary leprosy and is characterized by painful nodules and systemic compromising. It is usually recurrent and/or chronic and has both physical and economic impact on the patient, being a very important cause of disability. In addition, ENL is a major health problem in countries where leprosy is endemic. Therefore, adequate control of this condition is important. The management of ENL aims to control acute inflammation and neuritis and prevent the onset of new episodes. However, all currently available treatment modalities have one or two drawbacks and are not effective for all patients. Corticosteroid is the anti-inflammatory of choice in ENL but may cause dependence, especially for chronic patients. Thalidomide has a rapid action but its use is limited due the teratogenicity and neurotoxicity. Clofazimine and pentoxifylline have slow action and have important adverse effects. Finally, there is no pattern or guidelines for treating these patients, becoming more difficult to evaluate and to control this condition. This review aims to show the main drugs used in the treatment of ENL and the challenges in the management of the reaction.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Erythema Nodosum/drug therapy , Glucocorticoids/therapeutic use , Leprostatic Agents/therapeutic use , Leprosy, Lepromatous/drug therapy , Pentoxifylline/therapeutic use , Thalidomide/therapeutic use , Erythema Nodosum/immunology , Humans , Inflammation , Leprosy, Lepromatous/immunology , Neglected Diseases/drug therapy , Recurrence , Remission Induction , Treatment Outcome
16.
BMJ Case Rep ; 20182018 Jan 04.
Article in English | MEDLINE | ID: mdl-29301808

ABSTRACT

Coeliac disease (CD) is an autoimmune disease, characterised by a permanent sensitivity to gluten. It is being progressively recognised as a multisystemic disease, with multiple extraintestinal manifestations. Skin conditions (eg, dermatitis herpetiformis) are an example of its manifestations; however, its underlying mechanisms are still not well understood. This article presents three cases of uncommon skin conditions in patients with a history of CD. Two of them concern linear IgA bullous dermatosis and erythema nodosum, which have been described in the literature as having potential associations with CD, though only a few cases were reported. The third case corresponds to pityriasis lichenoides-a rare lymphoproliferative disorder of unknown aetiology-, which has no correlation with CD in the literature reviewed. The authors aim to draw attention to the possibility of CD as a potential predisposing factor for the occurrence of these skin diseases.


Subject(s)
Celiac Disease/complications , Erythema Nodosum/immunology , Linear IgA Bullous Dermatosis/immunology , Pityriasis Lichenoides/immunology , Adolescent , Celiac Disease/immunology , Child , Child, Preschool , Female , Humans , Male
17.
PLoS Negl Trop Dis ; 11(12): e0006121, 2017 12.
Article in English | MEDLINE | ID: mdl-29253897

ABSTRACT

B-cells, in addition to antibody secretion, have emerged increasingly as effector and immunoregulatory cells in several chronic inflammatory diseases. Although Erythema Nodosum Leprosum (ENL) is an inflammatory complication of leprosy, the role of B- cell subsets has never been studied in this patient group. Therefore, it would be interesting to examine the contribution of B-cells in the pathogenesis of ENL. A case-control study design was used to recruit 30 untreated patients with ENL and 30 non-reactional lepromatous leprosy (LL) patient controls at ALERT Hospital, Ethiopia. Peripheral blood samples were obtained before, during and after treatment from each patient. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of B- cell subsets by flow cytometry. The kinetics of B-cells in patients with ENL before, during and after Prednisolone treatment of ENL was compared with LL patient controls as well as within ENL group. Total B-cells, mature B-cells and resting memory B-cells were not significantly different between patients with ENL reactions and LL controls before treatment. Interestingly, while the percentage of naive B-cells was significantly lower in untreated ENL patients than in LL patient controls, the percentage of activated memory B-cells was significantly higher in these untreated ENL patients than in LL controls. On the other hand, the percentage of tissue-like memory B-cells was considerably low in untreated ENL patients compared to LL controls. It appears that the lower frequency of tissue-like memory B-cells in untreated ENL could promote the B-cell/T-cell interaction in these patients through downregulation of inhibitory molecules unlike in LL patients. Conversely, the increased production of activated memory B-cells in ENL patients could imply the scale up of immune activation through antigen presentation to T-cells. However, the generation and differential function of these memory B-cells need further investigation. The finding of increased percentage of activated memory B-cells in untreated patients with ENL reactions suggests the association of these cells with the ENL pathology. The mechanism by which inflammatory reactions like ENL affecting these memory cells and contributing to the disease pathology is an interesting area to be explored for and could lead to the development of novel and highly efficacious drug for ENL treatment.


Subject(s)
Antibodies, Bacterial/immunology , B-Lymphocytes/immunology , Erythema Nodosum/immunology , Erythema Nodosum/pathology , Leprosy/pathology , Mycobacterium leprae/immunology , Anti-Inflammatory Agents/therapeutic use , Case-Control Studies , Erythema Nodosum/drug therapy , Ethiopia , Humans , Immunologic Memory/immunology , Leprosy/immunology , Leprosy/microbiology , Lymphocyte Count , Prednisolone/therapeutic use , T-Lymphocytes/immunology
18.
PLoS Negl Trop Dis ; 11(10): e0006001, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28991896

ABSTRACT

Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4+ and CD8+ regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4+ regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4+regulatory T-cells was not significantly different between the two groups. The percentage of CD8+ regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4+ T-ells and CD4+/CD8+ T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4+ and CD8+ T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4+ T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4+ T-cell but not CD8+ T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4+/CD8+ T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL.


Subject(s)
Erythema Nodosum/etiology , Erythema Nodosum/immunology , Leprosy/complications , T-Lymphocytes/physiology , Adolescent , Adult , Anti-Inflammatory Agents/therapeutic use , Case-Control Studies , Erythema Nodosum/drug therapy , Female , Gene Expression Regulation/immunology , Humans , Interleukin-17/genetics , Interleukin-17/metabolism , Leprosy/immunology , Male , Middle Aged , Prednisolone/therapeutic use , T-Lymphocytes/classification , Young Adult
20.
J Eur Acad Dermatol Venereol ; 31(4): 705-711, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27859670

ABSTRACT

BACKGROUND: Leprosy reactions are immunologically mediated conditions and a major cause of disability before, during and after multidrug therapy (MDT). Little data have been published on the epidemiology of leprosy reactions in Bangladesh. OBJECTIVES: To describe the pattern and prevalence of leprosy reactions in the postelimination stage. METHODS: A descriptive retrospective cross-sectional study was carried out in Chittagong Medical College Hospital using the registered records of patients in the period between 2004 and 2013. RESULTS: Of the 670 patients with leprosy, 488 (73.38%) were males and 182 (27.37%) were females. The prevalence of reaction was in 300 (44.78%) patients with a male:female ratio of 3.55 : 1. The age-specific cumulative reaction cases at >40 years were 115 (38.33%) among all age groups. The prevalence of reaction was found to be in 166 (55.33%) patients for the reversal reaction, 49 (16.57%) for the erythema nodosum leprosum (ENL) and 85 (28.33%) for the neuritis. Borderline tuberculoid was most common (106, 35.33%)in the reversal reaction group, while lepromatous leprosy was most common (37, 12.33%) in ENL group. More than half of the patients (169, 56.33%) had reactions at the time of presentations, while 85 (28.33%) and 46 (15.33%) patients developed reaction during and after MDT, respectively. The reversal reaction group presented with ≥six skin lesions in 96 (57.83%) patients and ≥two nerve function impairments (NFIs) in 107 (64.46%) patients. The ENL was present chiefly as papulo-nodular lesions in 45 (91.84%) patients followed by pustule-necrotic lesions in four (8.16%), neuritis in 33 (67.35%), fever in 24 (48.98%), lymphadenitis in six (12.24%), arthritis in five (10.20%) and iritis in two (4.08%). Bacterial index ≥3 had been demonstrated in 34 (60.71%) patients in ENL group. CONCLUSION: The incidence of leprosy reaction seemed to be more than three times common in borderline tuberculoid (52.33%) group than in lepromatous leprosy (14%) group. Reactions with NFI and disability still occur among multibacillary patients during and after MDT. Early detection and management of leprosy reaction are very important in preventing disability and deformity, and patients should be educated to undergo regular follow-up examinations. Developing reinforced new therapies to curb leprosy reactions is crucial for improving leprosy healthcare services.


Subject(s)
Erythema Nodosum/immunology , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/epidemiology , Leprosy/drug therapy , Lymphadenitis/immunology , Neuritis/immunology , Adolescent , Adult , Antigens, Bacterial/immunology , Arthritis/epidemiology , Arthritis/immunology , Bangladesh/epidemiology , Child , Child, Preschool , Erythema Nodosum/epidemiology , Female , Humans , Infant , Iritis/epidemiology , Iritis/immunology , Leprostatic Agents/therapeutic use , Leprosy, Borderline/drug therapy , Leprosy, Lepromatous/drug therapy , Leprosy, Tuberculoid/drug therapy , Lymphadenitis/epidemiology , Male , Neuritis/epidemiology , Prevalence , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...